STAT+: BeOne wins FDA approval in lymphoma race

BeOne wins FDA approval in lymphoma race, while Biotech's cell therapy boom expands beyond cancer and CREATE Medicines raises $122 million to advance its in vivo CAR-T for autoimmune disease. The Trump administration is searching for a new FDA commissioner. BeOne's approval marks a significant development in the treatment of lymphoma.